Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis
Open Access
- 13 June 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (28), 44288-44298
- https://doi.org/10.18632/oncotarget.9988
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Ke Wang1, Jianjun Xu2, Tao Zhang1, Dan Xue3 1Department of Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China 2School of Finance, Zhejiang University of Finance and Economics, Hangzhou, 310018, China 3Department of Plastic Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China Correspondence to: Dan Xue, email: zxkdanxue@126.com Keywords: breast cancer, lymphocyte infiltrates, pathological complete response (pCR), prognosis, meta-analysis Received: February 23, 2016 Accepted: May 17, 2016 Published: June 13, 2016Keywords
This publication has 33 references indexed in Scilit:
- Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer PatientsJournal of Breast Cancer, 2013
- Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patientsBreast Cancer Research and Treatment, 2012
- Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patientsBreast Cancer Research and Treatment, 2012
- Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancerBreast Cancer Research, 2011
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to ChemotherapyCancer Discovery, 2011
- Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancerBreast Cancer Research and Treatment, 2011
- MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancerBreast Cancer Research, 2009
- Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancerBreast Cancer Research and Treatment, 2008
- Tumor immunoediting and immunosculpting pathways to cancer progressionSeminars in Cancer Biology, 2007
- Caspase-dependent immunogenicity of doxorubicin-induced tumor cell deathThe Journal of Experimental Medicine, 2005